scholarly journals New and experimental techniques in the treatment of benign prostatic diseases

2014 ◽  
Vol 61 (1) ◽  
pp. 75-80
Author(s):  
Tomislav Pejcic ◽  
Zoran Dzamic ◽  
Miodrag Acimovic ◽  
Boris Kajmakovic ◽  
Jovan Hadzi-Djokic
Keyword(s):  
Minimally Invasive ◽  
Treatment Modalities ◽  
Artery Embolization ◽  
Invasive Treatment ◽  
Urinary Tract Symptoms ◽  
High Prevalence ◽  
Prostatic Diseases ◽  
Invasive Techniques ◽  
Near Future ◽  
Lower Urinary

Background: Benign prostatic hyperplasia (BPH) and chronic prostatitis (CP) are disorders with high prevalence and have a great impact on overall morbidity in men. The patients that do not respond to medical therapy for lower urinary tract symptoms (LUTS) related to BPH are candidates for surgery. However, the number of men with BPH/LUTS seeking for non- surgical, or for less invasive treatment is growing. Aim: To present the basic information about minimally invasive treatment modalities for BPH and CP: intraprostatic injections, urethral lift procedures, modifications of transurethral microwave thermotherapy (TUMT), prostatic artery embolization etc. Conclusion: The majority of these techniques is still in experimental phase and not widely accepted. However, it is very likely that new, safe and minimally invasive techniques will appear in the near future.

scholarly journals Prostate artery embolization: a new, minimally invasive treatment for lower urinary tract symptoms secondary to prostate enlargement

2017 ◽  
Vol 9 (8) ◽  
pp. 209-216 ◽  
Author(s):  
Drew Maclean ◽  
Ben Maher ◽  
Sachin Modi ◽  
Mark Harris ◽  
Jonathan Dyer ◽  
...  
Keyword(s):  
Urinary Tract ◽  
Lower Urinary Tract ◽  
Benign Prostatic Obstruction ◽  
Artery Embolization ◽  
Invasive Treatment ◽  
Prostate Artery Embolization ◽  
Efficacious Treatment ◽  
Prostate Enlargement ◽  
Urinary Tract Symptoms ◽  
Lower Urinary

Prostate artery embolization (PAE) is emerging as a safe and efficacious treatment which approaches benign prostatic obstruction (BPO) from a unique perspective. This brings with it distinct advantages and solutions, which we discuss along with cost, evidence, complications and disadvantages.

scholarly journals iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia

2020 ◽  
Vol 12 ◽  
pp. 175628722093435
Author(s):  
Dhivya Balakrishnan ◽  
Patrick Jones ◽  
Bhaskar K. Somani
Keyword(s):  
Minimally Invasive ◽  
Second Generation ◽  
Short Term ◽  
Invasive Treatment ◽  
Prostate Enlargement ◽  
Urinary Tract Symptoms ◽  
Current Guidelines ◽  
Benign Prostate ◽  
Lower Urinary

iTIND is the second-generation version of the temporary nitinol implantable device (TIND), which has emerged over the past decade as one of the latest additions to the library of minimally invasive surgeries now available to treat bothersome lower urinary tract symptoms (LUTS) caused by benign prostate enlargement. While the key procedural steps remain the same, it now carries specific modifications designed to improve its efficacy and safety profile further. With the option to perform implantation under local anaesthesia, it can be delivered on an ambulatory basis and in the office setting. While the formal position of iTIND in current guidelines is yet to be determined, 12-month data demonstrates that it can improve both objective and subjective outcome measures, which are sustained at short-term follow up.

Sign in / Sign up

Export Citation Format

Share Document